Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study
View ORCID ProfileSascha Dublin, Rod Walker, James S. Floyd, Susan M. Shortreed, Sharon Fuller, Ladia Albertson-Junkans, Laura B. Harrington, Mikael Anne Greenwood-Hickman, Beverly B. Green, Bruce M. Psaty
doi: https://doi.org/10.1101/2020.07.06.20120386
Sascha Dublin
1Kaiser Permanente Washington Health Research Institute, Seattle, WA
2Department of Epidemiology, University of Washington, Seattle, WA
MD, PhDRod Walker
1Kaiser Permanente Washington Health Research Institute, Seattle, WA
MSJames S. Floyd
1Kaiser Permanente Washington Health Research Institute, Seattle, WA
2Department of Epidemiology, University of Washington, Seattle, WA
3Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA
MD, MSSusan M. Shortreed
1Kaiser Permanente Washington Health Research Institute, Seattle, WA
4Department of Biostatistics, University of Washington, Seattle, WA
PhDSharon Fuller
1Kaiser Permanente Washington Health Research Institute, Seattle, WA
BALadia Albertson-Junkans
1Kaiser Permanente Washington Health Research Institute, Seattle, WA
MPHLaura B. Harrington
1Kaiser Permanente Washington Health Research Institute, Seattle, WA
2Department of Epidemiology, University of Washington, Seattle, WA
PhD, MPHMikael Anne Greenwood-Hickman
1Kaiser Permanente Washington Health Research Institute, Seattle, WA
MPHBeverly B. Green
1Kaiser Permanente Washington Health Research Institute, Seattle, WA
MD, MPHBruce M. Psaty
1Kaiser Permanente Washington Health Research Institute, Seattle, WA
2Department of Epidemiology, University of Washington, Seattle, WA
3Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA
5Department of Health Services, University of Washington, Seattle, WA
MD, PhD
Posted July 07, 2020.
Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study
Sascha Dublin, Rod Walker, James S. Floyd, Susan M. Shortreed, Sharon Fuller, Ladia Albertson-Junkans, Laura B. Harrington, Mikael Anne Greenwood-Hickman, Beverly B. Green, Bruce M. Psaty
medRxiv 2020.07.06.20120386; doi: https://doi.org/10.1101/2020.07.06.20120386
Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study
Sascha Dublin, Rod Walker, James S. Floyd, Susan M. Shortreed, Sharon Fuller, Ladia Albertson-Junkans, Laura B. Harrington, Mikael Anne Greenwood-Hickman, Beverly B. Green, Bruce M. Psaty
medRxiv 2020.07.06.20120386; doi: https://doi.org/10.1101/2020.07.06.20120386
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)